The use of stelazine and parnate in chronic, withdrawn patients.
作者信息
VOGT A H
出版信息
Am J Psychiatry. 1961 Sep;118:256-7. doi: 10.1176/ajp.118.3.256.
PMID:13781857
Abstract
摘要
相似文献
1
The use of stelazine and parnate in chronic, withdrawn patients.
Am J Psychiatry. 1961 Sep;118:256-7. doi: 10.1176/ajp.118.3.256.
2
Trifluoperazine and Tranylcypromine in chronic refractory schizophrenics.
Am J Psychiatry. 1960 Dec;117:548-9. doi: 10.1176/ajp.117.6.548.
3
The unique therapeutic properties of tranylcypromine and trifluoperazine (parstelin).
Am J Psychiatry. 1960 Sep;117:245-6. doi: 10.1176/ajp.117.3.245.
4
The relative merits of tranylcypromine alone and tranylcypromine in combination with trifluoperazine in the treatment of patients with severe agitated depressions.
Am J Psychiatry. 1962 Apr;118:934-5. doi: 10.1176/ajp.118.10.934.
5
Combined use of tranylcypromine and trifluoperazine in ambulatory treatment of patients with agitated depressions: Preliminary evaluation.
N Y State J Med. 1961 Jun 1;61:1898-903.
6
The effect of tranylcypromine-trifluoperazine in the treatment of depressive states.
Can Psychiatr Assoc J. 1962;7(Suppl):84-6. doi: 10.1177/070674376200701s16.
7
The use of tranylcypromine and trifluoperazine in the management of coexisting depression and anxiety.
Can Psychiatr Assoc J. 1962;7(Suppl):87-90. doi: 10.1177/070674376200701s17.
8
Combined tranylcypromine-trifluoperazine therapy in obstetrics and gynaecology.
Can Psychiatr Assoc J. 1962;7(Suppl):77-83. doi: 10.1177/070674376200701s14.
9
The prediction of response to tranylcypromine plus trifluoperazine by the MMPI.
Am J Psychiatry. 1962 Jul;119:69-70. doi: 10.1176/ajp.119.1.69.
10
Neuropharmacology of tranylcypromine and trifluoperazine.
Can Psychiatr Assoc J. 1962;7(Suppl):55-9. doi: 10.1177/070674376200701s09.
引用本文的文献
1
Trifluoperazine for schizophrenia.
Cochrane Database Syst Rev. 2004;2004(1):CD003545. doi: 10.1002/14651858.CD003545.pub2.
Zotero 插件